Laboratory inspection items | Total | Short-term bedridden group | Middle-term bedridden group | Long-term bedridden group | P |
---|---|---|---|---|---|
M ± SD | N = 101 | N = 46 | N = 23 | N = 32 | |
WBC (× 109/l) | 10.21 ± 4.44 | 10.33 ± 3.83 | 9.6 ± 3.69 | 10.49 ± 5.67 | 0.750 |
NEU (%) | 78.5 ± 9.98 | 79.91 ± 11.38 | 77.84 ± 5.98 | 77.04 ± 10.13 | 0.432 |
HGB (g/l) | 114.3 ± 20.0 | 114 ± 19.31 | 114.2 ± 23.2 | 114.9 ± 19.1 | 0.982 |
PO2 (mmHg) | 76.21 ± 15.2 | 74.81 ± 11.25 | 74.7 ± 12.98 | 79.1 ± 20.55 | 0.438 |
PCO2 (mmHg) | 33.48 ± 5.8 | 32.4 ± 4.3 | 34.3 ± 5.59 | 34.6 ± 7.52 | 0.213 |
CRP (mg/l), n = 87 | 61.76 ± 62.1 | 80.49 ± 79.12 | 47.07 ± 38.35 | 52.56 ± 51.26 | 0.084 |
< 20 | 27 (31%) | 8 (24.2%) | 8 (36.4%) | 11 (34.4%) | 0.259 |
20–120 | 50 (57.5%) | 18 (54.5%) | 13 (59.1%) | 19 (59.4%) | |
> 120 | 10 (11.5%) | 7 (21.2%) | 1 (4.5%) | 2 (6.3%) | |
PCT (ng/ml), n = 49 | 2.07 ± 7.5 | 0.22 ± 0.38 | 6.21 ± 13.25 | 1.25 ± 5.49 | 0.105 |
< 0.1 | 28 (57.1%) | 9 (64.3%) | 5 (45.5%) | 14 (58.3%) | 0.545 |
0.1–25 | 18 (36.7%) | 5 (35.7%) | 4 (36.4%) | 9 (37.5%) | |
> 25 | 3 (6.1%) | 0 (0%) | 2 (18.2%) | 1 (4.2%) | |
HBA1C% | 5.9 ± 0.83 | 6.07 ± 0.98 | 6.02 ± 0.72 | 5.67 ± 0.59 | 0.124 |
ALB (g/l) | 37.89 ± 4.88 | 39.56 ± 4.56 | 36.6 ± 4.39 | 36.4 ± 5.01 | 0.006 |
sCr (μmol/l) | 69.5 ± 29.56 | 66.43 ± 22.98 | 74.4 ± 35.68 | 70.38 ± 33.4 | 0.564 |
Chest imaging abnormalities | |||||
Unilateral | 36 (35.6%) | 13 (28.3%) | 10 (43.5%) | 13 (40.6%) | 0.358 |
Biolateral | 65 (64.4%) | 33 (71.7%) | 13 (56.5%) | 19 (59.4%) |